The IFITM Proteins Inhibit HIV-1 Infection

被引:334
作者
Lu, Jennifer [1 ,2 ]
Pan, Qinghua [1 ]
Rong, Liwei [1 ]
Liu, Shan-Lu [3 ,4 ]
Liang, Chen [1 ,2 ,3 ]
机构
[1] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
[4] Univ Missouri, Dept Mol Microbiol & Immunol, Bond Life Sci Ctr, Columbia, MO 65211 USA
基金
加拿大健康研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; STABLE SIGNAL PEPTIDE; WEST NILE VIRUS; INTERFERON-ALPHA; T-CELLS; IFN-ALPHA; ENVELOPE GLYCOPROTEIN; DISTINCT MECHANISMS; REPLICATION INVITRO; ANTIVIRAL RESPONSE;
D O I
10.1128/JVI.01531-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type I interferon protects cells from virus infection through the induction of a group of genes collectively named interferon-stimulated genes (ISGs). In this study, we utilized short hairpin RNA (shRNA) to deplete ISGs in SupT1 cells in order to identify ISGs that suppress the production of human immunodeficiency virus type 1 (HIV-1). Among the ISG candidates thus identified were interferon-induced transmembrane (IFITM) proteins, including IFITM1, IFITM2, and IFITM3, that potently inhibit HIV-1 replication at least partially through interfering with virus entry. Further mutagenesis analysis shows that the intracellular region, rather than the N- and C-terminal extracellular domains, is essential for the antiviral activity of IFITM1. Altogether, these data suggest that the IFITM proteins serve as important components of the innate immune system to restrict HIV-1 infection.
引用
收藏
页码:2126 / 2137
页数:12
相关论文
共 50 条
  • [31] Defective HIV-1 proviruses produce viral proteins
    Imamichi, Hiromi
    Smith, Mindy
    Adelsberger, Joseph W.
    Izumi, Taisuke
    Scrimieri, Francesca
    Sherman, Brad T.
    Rehm, Catherine A.
    Imamichi, Tomozumi
    Pau, Alice
    Catalfamo, Marta
    Fauci, Anthony S.
    Lane, H. Clifford
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (07) : 3704 - 3710
  • [32] Proteomics in the investigation of HIV-1 interactions with host proteins
    Li, Ming
    PROTEOMICS CLINICAL APPLICATIONS, 2015, 9 (1-2) : 221 - 234
  • [33] Distinct Requirements for HIV-1 Accessory Proteins during Cell Coculture and Cell-Free Infection
    Zotova, Anastasia
    Atemasova, Anastasia
    Pichugin, Alexey
    Filatov, Alexander
    Mazurov, Dmitriy
    VIRUSES-BASEL, 2019, 11 (05):
  • [34] Sulfono-γ-AA modified peptides that inhibit HIV-1 fusion
    Bolarinwa, Olapeju
    Zhang, Meng
    Mulry, Erin
    Lu, Min
    Cai, Jianfeng
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2018, 16 (42) : 7878 - 7882
  • [35] New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection
    Garcia-Perez, Javier
    Rueda, Patricia
    Staropoli, Isabelle
    Kellenberger, Esther
    Alcami, Jose
    Arenzana-Seisdedos, Fernando
    Lagane, Bernard
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (07) : 4978 - 4990
  • [36] Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface
    Marlin, Romain
    Nugeyre, Marie-Therese
    Duriez, Marion
    Cannou, Claude
    Le Breton, Anne
    Berkane, Nadia
    Barre-Sinoussi, Francoise
    Menu, Elisabeth
    RETROVIROLOGY, 2011, 8
  • [37] Natural killer cells in HIV-1 infection and therapy
    Mikulak, Joanna
    Oriolo, Ferdinando
    Zaghi, Elisa
    Di Vito, Clara
    Mavilio, Domenico
    AIDS, 2017, 31 (17) : 2317 - 2330
  • [38] Innate signaling in HIV-1 infection of dendritic cells
    van der Vlist, Michiel
    van der Aar, Angelic M. G.
    Gringhuis, Sonja I.
    Geijtenbeek, Teunis B. H.
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (05) : 348 - 352
  • [39] Key Concepts in the Early Immunology of HIV-1 Infection
    Siewe, Basile
    Landay, Alan
    CURRENT INFECTIOUS DISEASE REPORTS, 2012, 14 (01) : 102 - 109
  • [40] Chemokine Coreceptor Signaling in HIV-1 Infection and Pathogenesis
    Wu, Yuntao
    Yoder, Alyson
    PLOS PATHOGENS, 2009, 5 (12)